ArticleNature biomedical engineering2026
Theoretical quantitative model and clinical outcome predictions of conductive cardiac patches for electrophysiological treatments.
Article in Nature biomedical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Effects of graphene oxide on grape growth, rhizosphere microbial diversity, and berry quality.Frontiers in plant science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
Abstract
Myocardial infarction (MI) impairs cardiac electrical signal transmission, which could be partially remedied by implantable electroactive biomaterials. Here we characterize electroactive cardiac patches (eCarPs) with conductivities spanning five orders of magnitude both in vitro and in rat models. In contrast to common belief, we reveal that highly conductive eCarPs are more effective in lowering the risk of post-MI arrhythmia and preserving cardiac function with respect to eCarPs with conductivity similar to normal myocardium. We show that highly conductive eCarPs restore electrical signal conduction velocity across infarcted myocardium to healthy levels, while less conductive eCarPs fail to do this. We quantitatively demonstrate that three-dimensional cardiac simulation based on the monodomain model accurately replicates the effect of high-conductivity patches in eliminating conduction blocks in porcine myocardium and the locations of reentrant circuits in patients with MI. Our results suggest that eCarP conductivity higher than healthy human myocardium is preferred for lowering the risk of arrhythmia in patients by reducing the number of reentrants and stabilizing the reentrant routes.
Identifiers
42014579What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.